Pitt B - Search Results

1

Mentz RJ, Kjeldsen K, Rossi GP, Voors AA, Cleland JG, Anker SD, Gheorghiade M, Fiuzat M, Rossignol P, Zannad F, Pitt B, O'Connor C, Felker GM. Mentz RJ, et al. Among authors: pitt b. Eur J Heart Fail. 2014 May;16(5):471-82. doi: 10.1002/ejhf.74. Epub 2014 Mar 5. Eur J Heart Fail. 2014. PMID: 24599738 Free PMC article. Review.

2

Digitalis Investigation Group (DIG) trial: a stimulus for further research.

Gheorghiade M, Pitt B. Gheorghiade M, et al. Among authors: pitt b. Am Heart J. 1997 Jul;134(1):3-12. doi: 10.1016/s0002-8703(97)70100-5. Am Heart J. 1997. PMID: 9266777 Review. No abstract available.

3

Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure: insights from the randomized aldactone evaluation study (RALES). Rales Investigators.

Zannad F, Alla F, Dousset B, Perez A, Pitt B. Zannad F, et al. Among authors: pitt b. Circulation. 2000 Nov 28;102(22):2700-6. doi: 10.1161/01.cir.102.22.2700. Circulation. 2000. PMID: 11094035 Clinical Trial.

4

Haemoglobin predicts survival in patients with chronic heart failure: a substudy of the ELITE II trial.

Sharma R, Francis DP, Pitt B, Poole-Wilson PA, Coats AJ, Anker SD. Sharma R, et al. Among authors: pitt b. Eur Heart J. 2004 Jun;25(12):1021-8. doi: 10.1016/j.ehj.2004.04.023. Eur Heart J. 2004. PMID: 15191772 Clinical Trial.

5

The role of aldosterone blockade in patients with heart failure.

Pitt B. Pitt B. Heart Fail Rev. 2005 Jan;10(1):79-83. doi: 10.1007/s10741-005-2352-2. Heart Fail Rev. 2005. PMID: 15947895 Free article. Review.

6

Eplerenone reduces mortality 30 days after randomization following acute myocardial infarction in patients with left ventricular systolic dysfunction and heart failure.

Pitt B, White H, Nicolau J, Martinez F, Gheorghiade M, Aschermann M, van Veldhuisen DJ, Zannad F, Krum H, Mukherjee R, Vincent J; EPHESUS Investigators. Pitt B, et al. J Am Coll Cardiol. 2005 Aug 2;46(3):425-31. doi: 10.1016/j.jacc.2005.04.038. J Am Coll Cardiol. 2005. PMID: 16053953 Free article. Clinical Trial.

7

Evaluation of eplerenone in the subgroup of EPHESUS patients with baseline left ventricular ejection fraction <or=30%.

Pitt B, Gheorghiade M, Zannad F, Anderson JL, van Veldhuisen DJ, Parkhomenko A, Corbalan R, Klug EQ, Mukherjee R, Solomon H; EPHESUS Investigators. Pitt B, et al. Eur J Heart Fail. 2006 May;8(3):295-301. doi: 10.1016/j.ejheart.2005.11.008. Epub 2006 Feb 28. Eur J Heart Fail. 2006. PMID: 16504579 Free article. Clinical Trial.

8

The Seattle Heart Failure Model: prediction of survival in heart failure.

Levy WC, Mozaffarian D, Linker DT, Sutradhar SC, Anker SD, Cropp AB, Anand I, Maggioni A, Burton P, Sullivan MD, Pitt B, Poole-Wilson PA, Mann DL, Packer M. Levy WC, et al. Among authors: pitt b. Circulation. 2006 Mar 21;113(11):1424-33. doi: 10.1161/CIRCULATIONAHA.105.584102. Epub 2006 Mar 13. Circulation. 2006. PMID: 16534009

9

Improving outcomes in post-acute myocardial infarction heart failure: incorporation of aldosterone blockade into combination therapy to optimize neurohormonal blockade.

Pitt B, Fonarow GC, Gheorghiade M, Deedwania PC, Duprez DA. Pitt B, et al. Am J Cardiol. 2006 May 22;97(10A):26F-33F. doi: 10.1016/j.amjcard.2006.03.006. Epub 2006 Apr 17. Am J Cardiol. 2006. PMID: 16698332 Review.

10

Role of aldosterone blockade for treatment of heart failure and post-acute myocardial infarction.

Greenberg B, Zannad F, Pitt B. Greenberg B, et al. Among authors: pitt b. Am J Cardiol. 2006 May 22;97(10A):34F-40F. doi: 10.1016/j.amjcard.2006.03.009. Epub 2006 Apr 7. Am J Cardiol. 2006. PMID: 16698333 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,209 results

Search Page